NCT07282119

Brief Summary

Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Aug 2025Aug 2026

Study Start

First participant enrolled

August 29, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2026

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 5, 2025

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Body Composition Measurement Form

    The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.

    Change from baseline (Day 1-3) in body measurements at 4 weeks after the start of the intervention (Day 27-33).

  • Quality of Life and Health Survey

    This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.

    Change from baseline (Day 1-3) in quality of life and health perceptions at 4 weeks after the start of the intervention (Day 27-33).

  • Body Image and Self-Perception Survey

    This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.

    Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).

Study Arms (1)

Single arm where participants act as their own control

EXPERIMENTAL

Single Arm observational where participants act as their own control

Device: EmeraldLED

Interventions

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm². The green light EmeraldLED therapy provided in this study is set at 525 nm.

Single arm where participants act as their own control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

You may not qualify if:

  • Individuals with eye conditions
  • Individuals not active with EmeraldLED

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Efforia

New York, New York, 10003, United States

RECRUITING

Related Links

Central Study Contacts

Matthew Amsden

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Single Arm observational where participants act as their own control
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2025

First Posted

December 15, 2025

Study Start

August 29, 2025

Primary Completion (Estimated)

August 29, 2026

Study Completion (Estimated)

August 29, 2026

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations